Alzheimer's Council Holds Final 2026 Meeting in DC

2026-20281, Global Benchmark for Efficient Drug Pricing (GLOBE) Model

Starting November 30, 2026, Medicare will use the new GLOBE Model to help lower the cost of certain drugs for people on Original Medicare. This model changes how drug price increases are calculated, aiming to save money for both patients and the Medicare program without cutting care quality. If you’re on Medicare Part B, expect smarter drug pricing that helps keep your healthcare affordable.

2026-19946, Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals (IPPS) and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year (FY) 2027 Rates; Requirements for Quality Programs; Other Policy Changes; and Adoption of Updated Versions of Certain Health Information Technology Standards; Correction

This update fixes some typos and technical mistakes in the Medicare payment rules for hospitals starting October 1, 2026. It affects hospitals getting paid for patient care, making sure the payment system and quality programs run smoothly. These corrections help hospitals get the right payments and follow updated health tech standards without delays or confusion.

2026-19493, Patient Protection and Affordable Care Act; Temporary Moratoria on Certain Agent and Broker Registration To Participate in the Exchanges

Starting now, new agents and brokers without a 2026 registration can’t sign up to help people enroll in health insurance through federal exchanges for 2027. This pause helps stop fraud and protect your info while CMS improves safety rules. If you’re already registered or working with state exchanges, this doesn’t affect you.

2026-17622, Federal Independent Dispute Resolution Operations; Correction

This document corrects typographical errors and omissions in the final rule that appeared in the June 4, 2026, Federal Register titled "Federal Independent Dispute Resolution Operations" (referred to hereafter as the "IDR final rule"). The effective date of the IDR final rule was August 3, 2026.

2026-16414, Adoption and Foster Care Analysis and Reporting System

This document withdraws a proposed rule that was published in the Federal Register on January 11, 2008. The proposed rule would have amended the Adoption and Foster Care Analysis and Reporting System (AFCARS) regulations at 45 CFR 1355.40 and the appendices to Part 1355 to modify the requirements for States to collect and report data to ACF on children in out-of-home care and in subsidized adoption or guardianship arrangements with the State. This document also withdraws the provision of the 2008 proposed rule that implemented the AFCARS penalty requirements of the Adoption Promotion Act of 2003 (Pub. L. 108-145).

2026-16296, Substances Generally Recognized as Safe

The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).

Previous: 2026-20384, Methionine From France, Japan, and Spain: Final Results of the Expedited First Sunset Reviews of the Antidumping Duty Orders

The U.S. Department of Commerce decided to keep special taxes on methionine imports from France, Japan, and Spain because dropping them could lead to unfair low prices again. This affects companies importing methionine and helps protect U.S. producers like Novus International. These rules stay in place until at least October 5, 2026, keeping the playing field fair and prices stable.

Next: 2026-20396, Sunshine Act Meetings

The SEC is holding a closed meeting on October 7, 2026, to discuss important legal and enforcement matters like lawsuits and investigations. This meeting affects SEC commissioners, staff, and anyone involved in these cases, but the public won’t be allowed in. No new costs or deadlines are announced, but changes to the meeting details will be posted online.